Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

FDA Approves AFib Monitor Algorithm for Mobile Devices

AliveECG app on an Android device (AliveCor Inc.)

21 August 2014. AliveCor Inc. in San Francisco says the U.S. Food and Drug Administration cleared an analytical processing algorithm to detect atrial fibrillation by its heart monitor designed for smartphones and tablets. FDA already cleared the basic AliveCor mobile device heart monitor system for . . . → Read More: FDA Approves AFib Monitor Algorithm for Mobile Devices

Analysis Uncovers Biotech Commercialization Bottlenecks

L-R: Jerry Thursby, Matthew Higgins and Marie Thursby (Georgia Institute of Technology)

21 August 2014. The path from scientific discovery in an academic lab to the marketplace is rarely a straightforward process, with researchers and entrepreneurs often facing detours and delays keeping new biomedical technologies in limbo for years at a time. Those . . . → Read More: Analysis Uncovers Biotech Commercialization Bottlenecks

Security Flaws Revealed in Full-Body X-Ray Scanner

UC San Diego computer scientist Hovav Shacham before a backscatter X-ray scanner (Erik Jepsen, UC San Diego)

20 August 2014. Computer scientists at three universities evaluated the backscatter X-ray scanners used in U.S. airports up to 2013, finding weapons could be readily concealed, and the device vulnerable to hacking. The team from University . . . → Read More: Security Flaws Revealed in Full-Body X-Ray Scanner

Medications, Phone Calls Boost Smoking Cessation Rates

(National Institute of Mental Health)

20 August 2014. Researchers at Massachusetts General Hospital in Boston found a combination of free medications and repeated automated telephone calls sharply cuts smoking rates among discharged patients, compared to patients receiving the standard counseling before leaving the hospital. The findings of the team led by Nancy Rigotti, . . . → Read More: Medications, Phone Calls Boost Smoking Cessation Rates

New Medical Technologies Investment Fund Raises $110M

(A. Kotok)

19 August 2014. HealthQuest Capital, a spin-off investment firm, says it raised $110 million for funding in technology-based start-ups serving the health care industry. The company was spun off from Sofinnova Ventures in Menlo Park, California and founded by Garheng Kong, a Sofinnova general partner.

HealthQuest plans to invest in companies . . . → Read More: New Medical Technologies Investment Fund Raises $110M

Novartis Acquires Stake in Stem Cell Therapy Company

Microscopic view of umbilical cord (Josef Reischig, Wikimedia Commons)

19 August 2014. Gamida Cell, a developer of therapies from umbilical cord stem cells, says the global pharmaceutical company Novartis is buying a 15 percent interest in the company, with an option to acquire the entire company later. The deal brings Gamida Cell, located . . . → Read More: Novartis Acquires Stake in Stem Cell Therapy Company

Engineered Fluid Devised for Lubricating Joint Cartilage

Jennifer Elisseeff (Johns Hopkins University)

18 August 2014. Biomedical engineers at Johns Hopkins University in Baltimore developed a synthetic lubrication fluid for natural or artificial joints in the body that emulates the properties of natural substances. A team led by Johns Hopkins medical professor Jennifer Elisseeff published its results earlier this month in . . . → Read More: Engineered Fluid Devised for Lubricating Joint Cartilage

$500K Challenge Seeks Techniques to Track Single Cells

(Daniel Borman/Flickr)

18 August 2014. A new challenge sponsored by National Institutes of Health is looking for better ways to follow and predict the functioning of a single cell in a complex multi-cell environment, such as in a tumor or a response to treatment. The competition, managed by the open-innovation/challenge company InnoCentive, expects . . . → Read More: $500K Challenge Seeks Techniques to Track Single Cells

Trial Testing Genetic Profiles for Personal Cancer Therapy

Apostolia M. Tsimberidou (MD Anderson Cancer Center)

15 August 2014. MD Anderson Cancer Center in Houston and Foundation Medicine in Cambridge, Massachusetts are testing the benefit of genetic profiles of tumors in determining personalized therapies for patients with metastatic cancer. The researchers conducting the trial also believe genetic profiling can better match cancer . . . → Read More: Trial Testing Genetic Profiles for Personal Cancer Therapy

System Tests Quality of Engineered Stem Cells, Tissue

Human embryonic stem cell colony (Clay Glennon/Univ of Wisconsin-Madison, NIGMS)

14 August 2014. Biomedical engineers and systems biologists developed an online system that tests the fidelity of engineered cells and tissue to the real-life properties of the cells they aim to emulate. The system, known as CellNet, is the creation of researchers from . . . → Read More: System Tests Quality of Engineered Stem Cells, Tissue